{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:26:51Z","timestamp":1783132011654,"version":"3.54.6"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The World Health Organization, Kampala, Uganda"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Between March,\u00a02020 and December, 2021 due to cholera and\u00a0coronavirus disease 2019 (COVID-19) pandemics, there were 1,534 cholera cases with 14 deaths and 136,065 COVID-19 cases with 3,285 deaths reported respectively in Uganda. This study investigated mass vaccination campaigns for the prevention of the two pandemics namely: oral cholera vaccine (OCV) and COVID-19 vaccine coverage; adverse events following immunization (AEFI); barriers and enablers for the vaccine uptake and assessed water, sanitation and hygiene (WASH) conditions in the six cholera and COVID-19 hotspot districts of Uganda.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A household survey was conducted between January and February, 2022 in the six cholera hotspot districts of Uganda which had recently conducted OCV mass vaccination campaigns and had ongoing COVID-19 mass vaccination campaigns. The survey randomly enrolled 900 households with 4,315 persons of whom 2,085 were above 18\u00a0years. Data were collected using a data entry application designed in KoBoToolbox and analysed using STATA version 14. Frequencies, percentages, odds ratios, means, confidence intervals and maps were generated and interpreted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The OCV coverage for dose one and two were 85% (95% CI: 84.2\u201486.4) and 67% (95% CI: 65.6\u201468.4) respectively. Among the 4,315 OCV recipients, 2% reported mild AEFI, 0.16% reported moderate AEFI and none reported severe AEFI. The COVID-19 vaccination coverage for dose one and two were 69.8% (95% CI: 67.8\u201371.8) and 18.8% (95% CI: 17.1\u201320.5) respectively. Approximately, 23% (478\/2,085) of COVID-19 vaccine recipient reported AEFI; most 94% were mild, 0.6% were moderate and 2 cases were severe. The commonest reason for missing COVID-19 vaccine was fear of the side effects. For most districts (5\/6), sanitation (latrine\/toilet) coverage were low at 7.4%\u201437.4%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There is high OCV coverage but low COVID-19 vaccine and sanitation coverage with high number of moderate cases of AEFI recorded due to COVID-19 vaccines. The low COVID-19 vaccine coverage could indicate vaccine hesitancy for COVID-19 vaccines. Furthermore, incorporation of WASH conditions assessment in the OCV coverage surveys is recommended for similar settings to generate data for better planning. However, more studies are required on COVID-19 vaccine hesitancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08462-y","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T09:02:17Z","timestamp":1689930137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cholera and COVID-19 pandemic prevention in multiple hotspot districts of Uganda: vaccine coverage, adverse events following immunization and WASH conditions survey"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8376-2857","authenticated-orcid":false,"given":"Godfrey","family":"Bwire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annet","family":"Kisakye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Amulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Baptist","family":"Bwanika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Badebye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Aanyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda Doreen","family":"Nakirya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Okello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Acellam","family":"Okello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine N.","family":"Bukenya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Garimoi","family":"Orach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"8462_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41182-021-00376-2","volume":"49","author":"O Uwishema","year":"2021","unstructured":"Uwishema O, Okereke M, Onyeaka H, Hasan MM, Donatus D, Martin Z, et al. Threats and outbreaks of cholera in Africa amidst COVID-19 pandemic: a double burden on Africa\u2019s health systems. Trop Med Health. 2021;49:1\u20135.","journal-title":"Trop Med Health"},{"key":"8462_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fpubh.2020.00241","volume":"8","author":"A Pak","year":"2020","unstructured":"Pak A, Adegboye OA, Adekunle AI, Rahman KM, McBryde ES, Eisen DP. Economic consequences of the COVID-19 outbreak: the need for epidemic preparedness. Front Public Heal. 2020;8:241.","journal-title":"Front Public Heal"},{"key":"8462_CR3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/jmv.25766","volume":"92","author":"F He","year":"2020","unstructured":"He F, Deng Y, Li W. Coronavirus disease 2019: what we know? J Med Virol. 2020;92:719\u201325.","journal-title":"J Med Virol"},{"key":"8462_CR4","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.3389\/fmicb.2020.631736","volume":"11","author":"J Piret","year":"2021","unstructured":"Piret J, Boivin G. Pandemics throughout history. Front Microbiol. 2021;11:3594.","journal-title":"Front Microbiol"},{"key":"8462_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/1469-0691.12390","volume":"20","author":"D Lippi","year":"2014","unstructured":"Lippi D, Gotuzzo E. The greatest steps towards the discovery of Vibrio cholerae. Clin Microbiol Infect. 2014;20:191\u20135.","journal-title":"Clin Microbiol Infect"},{"key":"8462_CR6","doi-asserted-by":"publisher","first-page":"A31","DOI":"10.1016\/j.vaccine.2019.07.078","volume":"38","author":"J Deen","year":"2020","unstructured":"Deen J, Mengel MA, Clemens JD. Epidemiology of cholera. Vaccine. 2020;38:A31\u201340.","journal-title":"Vaccine"},{"key":"8462_CR7","doi-asserted-by":"publisher","first-page":"E7730","DOI":"10.1073\/pnas.1608732113","volume":"113","author":"D Hu","year":"2016","unstructured":"Hu D, Liu B, Feng L, Ding P, Guo X, Wang M, et al. Origins of the current seventh cholera pandemic. Proc Natl Acad Sci U S A. 2016;113:E7730\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8462_CR8","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/ije\/dyt229","volume":"42","author":"DA Sack","year":"2013","unstructured":"Sack DA. A new era in the history of cholera: the road to elimination. Int J Epidemiol. 2013;42:1537\u201340.","journal-title":"Int J Epidemiol"},{"key":"8462_CR9","first-page":"445","volume-title":"Weekly Epidemiological Record","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. Cholera, 2020. In: Weekly epidemiological record. 2021. p. 445\u201360 https:\/\/reliefweb.int\/sites\/reliefweb.int\/files\/resources\/WER9637-eng-fre_0.pdf.\u00a0Accessed 10 May 2022."},{"key":"#cr-split#-8462_CR10.1","unstructured":"World Health Organization. Weekly Epidemiological Record (WER), 16 September 2022, Vol. 97, No 37, 2022, pp. 453-464 [EN\/FR] - World | ReliefWeb. Weekly epidemiological record (WER)"},{"key":"#cr-split#-8462_CR10.2","unstructured":"2022. https:\/\/reliefweb.int\/report\/world\/weekly-epidemiological-record-wer-16-september-2022-vol-97-no-37-2022-pp-453-464-enfr. Accessed 31 May 2023."},{"key":"8462_CR11","first-page":"668","volume":"1","author":"J Snow","year":"1856","unstructured":"Snow J. On the mode of communication of cholera. Edinb Med J. 1856;1:668\u201370.","journal-title":"Edinb Med J"},{"key":"8462_CR12","doi-asserted-by":"publisher","first-page":"e0226549","DOI":"10.1371\/journal.pone.0226549","volume":"15","author":"L D\u2019Mello-Guyett","year":"2020","unstructured":"D\u2019Mello-Guyett L, Gallandat K, Van Den Bergh R, Taylor D, Bulit G, Legros D, et al. Prevention and control of cholera with household and community water, sanitation and hygiene (WASH) interventions: a scoping review of current international guidelines. PLoS One. 2020;15:e0226549.","journal-title":"PLoS One"},{"key":"8462_CR13","volume-title":"Guidance on how to access the Oral Cholera Vaccine (OCV) from the ICG emergency stockpile","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Guidance on how to access the Oral Cholera Vaccine (OCV) from the ICG emergency stockpile. 2013."},{"key":"8462_CR14","first-page":"32","volume-title":"Glob task force cholera control","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Ending cholera: a global roadmap to 2030. In: Glob task force cholera control. 2017. p. 32."},{"key":"8462_CR15","unstructured":"World Health Organization. Immunization , vaccines and biologicals. World Health Organization; 2014. p. 1\u20133. https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/diseases\/cholera. Accessed 10 May 2022."},{"key":"8462_CR16","volume-title":"Addendum to \u201c Oral cholera vaccines in mass immunization campaigns. Guidance for planning and use .\u201d","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Addendum to \u201c Oral cholera vaccines in mass immunization campaigns. Guidance for planning and use .\u201d 2013."},{"key":"8462_CR17","unstructured":"World Health Organization. WHO director-general\u2019s opening remarks at the media briefing on COVID-19 - 11 March 2020. World Health Organization; 2020. https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed 10 May 2022."},{"key":"8462_CR18","first-page":"1","volume-title":"WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. Geneva: World Health Organization; 2022. p. 1\u20135."},{"key":"8462_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-022-02367-4","volume":"20","author":"G Bwire","year":"2022","unstructured":"Bwire G, Ario AR, Eyu P, Ocom F, Wamala JF, Kusi KA, et al. The COVID-19 pandemic in the African continent. BMC Med. 2022;20:1\u201323.","journal-title":"BMC Med"},{"key":"8462_CR20","doi-asserted-by":"crossref","unstructured":"Koh WC, Naing L, Chaw L, Rosledzana MA, Alikhan MF, Jamaludin SA, et al. What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors. PLoS One. 2020;15.","DOI":"10.1101\/2020.05.21.20108746"},{"key":"8462_CR21","first-page":"1","volume-title":"Transmission of SARS-CoV-2\u202f: implications for infection prevention precautions","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Transmission of SARS-CoV-2\u202f: implications for infection prevention precautions. 2020. p. 1\u201310."},{"key":"8462_CR22","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1016\/S0140-6736(12)60436-X","volume":"379","author":"JB Harris","year":"2012","unstructured":"Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. Cholera. Lancet. 2012;379:2466\u201376 Elsevier B.V.","journal-title":"Lancet"},{"key":"8462_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-7622-11-1","volume":"11","author":"ICH Fung","year":"2014","unstructured":"Fung ICH. Cholera transmission dynamic models for public health practitioners. Emerg Themes Epidemiol. 2014;11:1.","journal-title":"Emerg Themes Epidemiol"},{"key":"8462_CR24","unstructured":"John Hopkins University. Coronavirus COVID-19 (SARS-CoV-2). Johns Hopkins ABX Guide; 2022. https:\/\/www.hopkinsguides.com\/hopkins\/view\/Johns_Hopkins_ABX_Guide\/540747\/all\/Coronavirus_COVID_19__SARS_CoV_2_. Accessed 10 May 2022."},{"key":"8462_CR25","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W Guan","year":"2020","unstructured":"Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708\u201320.","journal-title":"N Engl J Med"},{"key":"8462_CR26","volume-title":"Severe acute respiratory infections treatment centre","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Severe acute respiratory infections treatment centre. 2020."},{"key":"8462_CR27","first-page":"1","volume-title":"Home care for patients with suspected or confirmed COVID-19 and management of their contacts","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Home care for patients with suspected or confirmed COVID-19 and management of their contacts. Geneva: World Health Organization; 2020. p. 1\u20139."},{"key":"8462_CR28","unstructured":"NIH. Prevention of SARS-CoV-2 | COVID-19 treatment guidelines. National Institutes of Health; 2022. https:\/\/www.covid19treatmentguidelines.nih.gov\/overview\/prevention-of-sars-cov-2\/. Accessed 12 May 2022."},{"key":"8462_CR29","unstructured":"World Health Organization. Tracking SARS-CoV-2 variants. WHO; 2021.\u00a0https:\/\/www.who.int\/en\/activities\/tracking-SARS-Co."},{"key":"8462_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/D41586-021-02177-3","author":"E Callaway","year":"2021","unstructured":"Callaway E. Remember beta? New data reveal variant\u2019s deadly powers. Nature. 2021. https:\/\/doi.org\/10.1038\/D41586-021-02177-3.","journal-title":"Nature"},{"key":"8462_CR31","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.21.21259268","author":"W Yang","year":"2021","unstructured":"Yang W, Shaman J. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination. medRxiv\u00a0Prepr Serv Heal Sci. 2021. https:\/\/doi.org\/10.1101\/2021.06.21.21259268.","journal-title":"medRxiv\u00a0Prepr Serv Heal Sci"},{"key":"8462_CR32","first-page":"15","volume":"0","author":"B Hewins","year":"2022","unstructured":"Hewins B, Rahman M, Bermejo-Martin JF, Kelvin AA, Richardson CD, Rubino S, et al. Alpha, beta, delta, omicron, and SARS-CoV-2 breakthrough cases: defining immunological mechanisms for vaccine waning and vaccine-variant mismatch. Front Virol. 2022;0:15.","journal-title":"Front Virol."},{"issue":"suppl_3","key":"8462_CR33","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1093\/infdis\/jiy486","volume":"218","author":"D Legros","year":"2018","unstructured":"Legros D. Global cholera epidemiology: opportunities to reduce the burden of cholera by 2030. J Infect Dis. 2018;218(suppl_3):S137\u201340.","journal-title":"J Infect Dis"},{"key":"8462_CR34","doi-asserted-by":"publisher","first-page":"e2545","DOI":"10.1371\/journal.pntd.0002545","volume":"7","author":"G Bwire","year":"2013","unstructured":"Bwire G, Malimbo M, Maskery B, Kim YE, Mogasale V, Levin A. The burden of cholera in Uganda. PLoS Negl Trop Dis. 2013;7:e2545.","journal-title":"PLoS Negl Trop Dis"},{"key":"8462_CR35","unstructured":"Ministry of Health U. Covid-19 response hub\/timeline. Ministry of Health (MoH) Uganda; 2020. https:\/\/covid19.gou.go.ug\/timeline.html. Accessed 13 May 2022."},{"key":"8462_CR36","unstructured":"Centers for Disease Control and Prevention (CDC). Five basic cholera prevention steps | Cholera | CDC. Cdc.gov; 2020. https:\/\/www.cdc.gov\/cholera\/preventionsteps.html. Accessed 13 Jun 2022."},{"key":"8462_CR37","unstructured":"World Health Organization. Advice for the public: Coronavirus disease (COVID-19). World Health Organization; 2022. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/advice-for-public. Accessed 13 Jun 2022."},{"key":"8462_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/tropicalmed6010032","volume":"6","author":"J Deen","year":"2021","unstructured":"Deen J, Clemens JD. Licensed and recommended inactivated oral choleravaccines: From development to innovative deployment. Trop Med Infect Dis. 2021;6:32.","journal-title":"Trop Med Infect Dis"},{"key":"8462_CR39","unstructured":"United Nations. How can we end COVID? The UN\u2019s global vaccine strategy. UN Web TV; 2021. https:\/\/media.un.org\/en\/asset\/k1x\/k1xtz75djz. Accessed 6 Jun 2022."},{"key":"8462_CR40","doi-asserted-by":"publisher","first-page":"e038464","DOI":"10.1136\/bmjopen-2020-038464","volume":"10","author":"G Bwire","year":"2020","unstructured":"Bwire G, Roskosky M, Ballard A, Brooks WA, Okello A, Rafael F, et al. Use of surveys to evaluate an integrated oral cholera vaccine campaign in response to a cholera outbreak in Hoima district. Uganda BMJ Open. 2020;10:e038464.","journal-title":"Uganda BMJ Open"},{"key":"8462_CR41","volume-title":"Gavi update: OCV support and vaccine investment strategy","author":"Gavi","year":"2018","unstructured":"Gavi. Gavi update: OCV support and vaccine investment strategy. 2018. https:\/\/www.fondation-merieux.org\/wp-content\/uploads\/2018\/10\/6th-annual-meeting-of-gtfcc-adam-soble.pdf.\u00a0Accessed 23 Jul 2022."},{"key":"8462_CR42","doi-asserted-by":"publisher","first-page":"e0006118","DOI":"10.1371\/journal.pntd.0006118","volume":"11","author":"G Bwire","year":"2017","unstructured":"Bwire G, Ali M, Sack DA, Nakinsige A, Naigaga M, Debes AK, et al. Identifying cholera \u201chotspots\u201d in Uganda: an analysis of cholera surveillance data from 2011 to 2016. PLoS Negl Trop Dis. 2017;11:e0006118.","journal-title":"PLoS Negl Trop Dis"},{"key":"8462_CR43","unstructured":"Ministry of Health U. National integrated comprehensive cholera prevention and control plan, fiscal years (2017\/18\u20132021\/22). Ministry of Health; 2017. http:\/\/health.go.ug\/content\/national-integrated-comprehensive-cholera-prevention-and-control-plan-fiscal-years-201718. Accessed 4 May 2018."},{"key":"8462_CR44","volume-title":"Weekly epidemiological surveillance reporting and HMIS 033B reported data","author":"Ministry of Health U","year":"2020","unstructured":"Ministry of Health U. Weekly epidemiological surveillance reporting and HMIS 033B reported data. 2020."},{"key":"8462_CR45","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard. WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. Geneva: World Health Organization. 2021. p. 1\u20135."},{"key":"8462_CR46","first-page":"477","volume":"92","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Cholera vaccines: WHO position paper \u2013 August 2017. Relev Epidemiol Hebd. 2017;92:477\u201398.","journal-title":"Relev Epidemiol Hebd"},{"key":"8462_CR47","first-page":"1","volume-title":"Coronavirus disease (COVID-19): Vaccines","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Coronavirus disease (COVID-19): Vaccines. Geneva: World Health Organization; 2020. p. 1."},{"key":"8462_CR48","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ijid.2022.03.007","volume":"118","author":"DS Lee","year":"2022","unstructured":"Lee DS, Kim JW, Lee KL, Jung YJ, Kang HW. Adverse events following COVID-19 vaccination in South Korea between February 28 and August 21, 2021: a nationwide observational study. Int J Infect Dis. 2022;118:173\u201382.","journal-title":"Int J Infect Dis"},{"key":"8462_CR49","unstructured":"World Health Organization. Ministry of Health and Partners Step-up COVID-19 vaccination in Uganda through accelerated mass vaccination campaigns. WHO | Regional Office for Africa; 2022. https:\/\/www.afro.who.int\/countries\/uganda\/news\/ministry-health-and-partners-step-covid-19-vaccination-uganda-through-accelerated-mass-vaccination. Accessed 15 May 2023."},{"key":"8462_CR50","first-page":"308","volume":"14","author":"O Ohwo","year":"2018","unstructured":"Ohwo O, Agusomu TD. Assessment of water, sanitation and hygiene services in sub-Saharan Africa. Eur Sci J ESJ. 2018;14:308.","journal-title":"Eur Sci J ESJ"},{"key":"8462_CR51","doi-asserted-by":"publisher","first-page":"e0198592","DOI":"10.1371\/journal.pone.0198592","volume":"13","author":"CS Baltazar","year":"2018","unstructured":"Baltazar CS, Rafael F, Langa JPM, Chicumbe S, Cavailler P, Gessner BD, et al. Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique. PLoS One. 2018;13:e0198592.","journal-title":"PLoS One"},{"key":"8462_CR52","doi-asserted-by":"publisher","first-page":"e2465","DOI":"10.1371\/journal.pntd.0002465","volume":"17","author":"FJ Luquero","year":"2013","unstructured":"Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, et al. First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012. PLoS Negl Trop Dis. 2013;17:e2465.","journal-title":"PLoS Negl Trop Dis"},{"key":"8462_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-022-12610-5","volume":"22","author":"J Ateudjieu","year":"2022","unstructured":"Ateudjieu J, Yakum MN, Goura AP, Tembei Ayok M, Guenou E, Kangmo Sielinou CB, et al. An innovative approach in monitoring oral cholera vaccination campaign: integration of a between-round survey. BMC Public Health. 2022;22:1\u201313.","journal-title":"BMC Public Health"},{"key":"8462_CR54","unstructured":"ESRI, Redlands, California US. Arcmap software | ArcGIS Pro. Version 10.5. https:\/\/www.esri.com\/en-us\/arcgis\/products\/arcgis-pro\/overview. Accessed 15 May 2023."},{"key":"8462_CR55","first-page":"253","volume":"60","author":"RH Henderson","year":"1982","unstructured":"Henderson RH, Sundaresan T. Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. Bull World Health Organ. 1982;60:253\u201360.","journal-title":"Bull World Health Organ"},{"key":"8462_CR56","unstructured":"reliefweb. Uganda receives 864,000 doses of COVID-19 vaccines - Uganda | ReliefWeb. ReliefWeb; 2021. https:\/\/reliefweb.int\/report\/uganda\/uganda-receives-864000-doses-covid-19-vaccines. Accessed 16 May 2023."},{"key":"8462_CR57","unstructured":"KoBoToolbox. KoBoToolbox | Data collection tools for challenging environments. Kobo Toolbox; 2021. https:\/\/www.kobotoolbox.org\/. Accessed 20 Jul 2022."},{"key":"8462_CR58","unstructured":"StataCorp. Statistical software for data science | Stata. Release 15. 2015. https:\/\/www.stata.com\/. Accessed 15 May 2023."},{"key":"8462_CR59","volume-title":"Uganda Districts Shapefiles 2020","author":"UNHCR","year":"2020","unstructured":"UNHCR. Uganda Districts Shapefiles 2020. 2020. https:\/\/data.unhcr.org\/en\/documents\/details\/83043.\u00a0Accessed 17 Jun 2022."},{"key":"8462_CR60","doi-asserted-by":"publisher","first-page":"954","DOI":"10.4269\/ajtmh.23-0007","volume":"108","author":"G Bwire","year":"2023","unstructured":"Bwire G, Sack DA, Lunkuse SM, Ongole F, Ngwa MC, Namanya DB, et al. Development of a scorecard to monitor progress toward national cholera elimination: its application in Uganda. Am J Trop Med Hyg. 2023;108:954\u201362.","journal-title":"Am J Trop Med Hyg"},{"key":"8462_CR61","unstructured":"World Health Organization. WHO coronavirus (COVID-19) dashboard | WHO coronavirus (COVID-19) dashboard with vaccination data. World Health Organization; 2022. https:\/\/covid19.who.int\/. Accessed 6 Jun 2022."},{"key":"8462_CR62","doi-asserted-by":"publisher","first-page":"e0005407","DOI":"10.1371\/journal.pntd.0005407","volume":"11","author":"G Bwire","year":"2017","unstructured":"Bwire G, Munier A, Ouedraogo I, Heyerdahl L, Komakech H, Kagirita A, et al. Epidemiology of cholera outbreaks and socio-economic characteristics of the communities in the fishing villages of Uganda: 2011\u20132015. PLoS Negl Trop Dis. 2017;11:e0005407.","journal-title":"PLoS Negl Trop Dis"},{"key":"8462_CR63","volume-title":"Covid-19 response info hub","author":"Ministry of Health U","year":"2022","unstructured":"Ministry of Health U. Covid-19 response info hub. 2022. https:\/\/covid19.gou.go.ug\/.\u00a0Accessed 8 Jun 2022."},{"key":"8462_CR64","first-page":"146","volume":"9","author":"Y Shang","year":"2021","unstructured":"Shang Y, Li H, Zhang R. Effects of pandemic outbreak on economies: evidence from business history context. Front Public Heal. 2021;9:146.","journal-title":"Front Public Heal"},{"key":"8462_CR65","doi-asserted-by":"publisher","first-page":"108818","DOI":"10.1016\/j.clim.2021.108818","volume":"230","author":"M Garc\u00eda-Grimshaw","year":"2021","unstructured":"Garc\u00eda-Grimshaw M, Michel-Ch\u00e1vez A, Vera-Zertuche JM, Galnares-Olalde JA, Hern\u00e1ndez-Vanegas LE, Figueroa-Cucurachi M, et al. Guillain-Barr\u00e9 syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine. Clin Immunol. 2021;230:108818.","journal-title":"Clin Immunol"},{"key":"8462_CR66","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3390\/vaccines9060674","volume":"9","author":"A Alhazmi","year":"2021","unstructured":"Alhazmi A, Alamer E, Daws D, Hakami M, Darraj M, Abdelwahab S, et al. Evaluation of side effects associated with covid-19 vaccines in Saudi Arabia. Vaccines. 2021;9:674.","journal-title":"Vaccines"},{"key":"8462_CR67","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1016\/S2214-109X(21)00563-5","volume":"10","author":"PN Mutombo","year":"2022","unstructured":"Mutombo PN, Fallah MP, Munodawafa D, Kabel A, Houeto D, Goronga T, et al. COVID-19 vaccine hesitancy in Africa: a call to action. Lancet Glob Health. 2022;10:e320\u20131.","journal-title":"Lancet Glob Health"},{"key":"8462_CR68","doi-asserted-by":"publisher","first-page":"702","DOI":"10.7196\/SAMJ.2021.v111i8.15800","volume":"111","author":"S Cooper","year":"2021","unstructured":"Cooper S, van Rooyen H, Wiysonge CS. COVID-19 vaccine hesitancy in South Africa: a complex social phenomenon. S Afr Med J. 2021;111:702\u20133.","journal-title":"S Afr Med J"},{"key":"8462_CR69","doi-asserted-by":"publisher","first-page":"A132","DOI":"10.1016\/j.vaccine.2019.08.086","volume":"38","author":"L Pezzoli","year":"2020","unstructured":"Pezzoli L. Global oral cholera vaccine use, 2013\u20132018. Vaccine. 2020;38:A132\u201340.","journal-title":"Vaccine"},{"key":"8462_CR70","unstructured":"World Health Organization. Africa faces 470 million COVID-19 vaccine shortfall in 2021. WHO | Regional Office for Africa; 2021. https:\/\/www.afro.who.int\/news\/africa-faces-470-million-covid-19-vaccine-shortfall-2021. Accessed 18 Jun 2022."},{"key":"8462_CR71","doi-asserted-by":"publisher","first-page":"6837","DOI":"10.2147\/IJGM.S372386","volume":"15","author":"A Kabagenyi","year":"2022","unstructured":"Kabagenyi A, Wasswa R, Nannyonga BK, Nyachwo EB, Kagirita A, Nabirye J, et al. Factors associated with COVID-19 vaccine hesitancy in Uganda: a population-based cross-sectional survey. Int J Gen Med. 2022;15:6837\u201347.","journal-title":"Int J Gen Med"},{"key":"8462_CR72","first-page":"1","volume":"1","author":"CDC Africa","year":"2022","unstructured":"Africa CDC. Partnerships for African Vaccine Manufacturing (PAVM). Version. 2022;1:1\u201399.","journal-title":"Version"},{"key":"8462_CR73","volume-title":"WASH (Water, Sanitation & Hygiene) and COVID-19","author":"World Bank","year":"2020","unstructured":"World Bank. WASH (Water, Sanitation & Hygiene) and COVID-19. 2020. https:\/\/www.worldbank.org\/en\/topic\/water\/brief\/wash-water-sanitation-hygiene-and-covid-19.\u00a0Accessed 8 Jun 2022."},{"key":"8462_CR74","volume-title":"Collecting wash data in OCV coverage surveys","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Collecting wash data in OCV coverage surveys. 2020."},{"key":"8462_CR75","unstructured":"United Nations | Department of Economic and Social Affairs. SDG goal 6: ensure availability and sustainable management of water and sanitation for all. United Nations; 2020. https:\/\/sdgs.un.org\/goals\/goal6. Accessed 17 Jun 2022."},{"key":"8462_CR76","doi-asserted-by":"publisher","first-page":"e1289","DOI":"10.1371\/journal.pntd.0001289","volume":"5","author":"D Sur","year":"2011","unstructured":"Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis. 2011;5:e1289.","journal-title":"PLoS Negl Trop Dis"},{"key":"8462_CR77","unstructured":"UNOCHA. Hygiene and sanitation: how communities take charge - world. ReliefWeb; 2020. https:\/\/reliefweb.int\/report\/world\/hygiene-and-sanitation-how-communities-take-charge. Accessed 16 Jun 2022."},{"key":"8462_CR78","doi-asserted-by":"publisher","first-page":"e0156674","DOI":"10.1371\/journal.pone.0156674","volume":"11","author":"G Bwire","year":"2016","unstructured":"Bwire G, Mwesawina M, Baluku Y, Kanyanda SSE, Orach CG. Cross-border cholera outbreaks in sub-Saharan Africa, the mystery behind the silent illness: what needs to be done? PLoS One. 2016;11:e0156674.","journal-title":"PLoS One"},{"key":"8462_CR79","volume-title":"WMA Declaration of Helsinki \u2013 Ethical Principles for Medical Research Involving Human Subjects","author":"World Medical Association","year":"1964","unstructured":"World Medical Association. WMA Declaration of Helsinki \u2013 ethical principles for medical research involving human subjects. 1964. https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/.\u00a0Accessed 23 Jun 2023."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08462-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08462-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08462-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T09:03:56Z","timestamp":1689930236000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08462-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8462"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08462-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1997127\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"26 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Makerere University Research and Ethical Committee (SPHREC), study reference No. SPH-2021\u2013179. From conception to implementation of this study, the research team adhered to the Declaration of Helsinki [\n                      \n                      ]. Furthermore, in order for the respondents to participate in the survey, written informed consent was obtained from them or their legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All other authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"487"}}